Model
Edge
Regeneron Pharmaceuticals, Inc.
0001681643
Filing Type
144
Filing Date
1/1/2024
Updated
1/2/24, 9:06 AM
Filing
144
Earnings Release
Exhibits
144
Notice of Proposed Sale of Securities